-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group: Striving with Full Vigor for Rapid Development and Launching a All-Out Sprint in the Third Quarter
Category:
发布时间：2022-09-08
【概要描述】
Shijiazhuang Sihua Pharmaceutical is strategically coordinating its efforts to foster both domestic and international market circulation, redoubling its commitment to accelerate production organization, ensure market supply, advance research and development, and expedite project construction. The company is making a full-scale push in the third quarter, striving to contribute to the city’s goal of surpassing RMB 1 trillion in economic output.
On September 7, the production workshops in the High-tech Industrial Development Zone of Shijiazhuang Sihua Pharmaceutical Group were bustling with activity across all production lines.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. is strategically coordinating its domestic and international market operations to foster a dual-circulation development model, mobilizing full momentum to accelerate production organization, market supply assurance, research and development, and project construction. The company is making all-out efforts to deliver strong performance in the third quarter and contribute to the city’s goal of surpassing RMB 1 trillion in economic output. From January to August this year, Shijiazhuang No. 4 Pharmaceutical Group achieved double-digit growth in both sales revenue and profits and taxes.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091